P14-04. HIV-SELECTEST EIA and rapid test: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies by Salim AK, Mlisana K, Busch MP, Norris PJ, Khurana S, Hunter E, Golding H

New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants by Penezina O, Clapham D, Collins J, Kovalenko V, Krueger N, Rodriguez-Chavez IR, Busch MP, Levin AE

Genomic and epidemiological characterisation of a dengue virus outbreak among blood donors in Brazil by Faria, N, da Costa, AC, Lourenco, J, Lopes, ME, Ribeiro, R, Alenca, CS, Kraemer, MUG, Villabona-Arenas, CJ, Wu, CH, Theze, J, Khan, K, Brent, SE, Romano, C, Delwart, E, Custer, B, Busch, MP, Pybus, OG, Sabino, EC

Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil by Prete, CA, Buss, LF, Buccheri, R, Abrahim, CMM, Salomon, T, Crispim, MAE, Oikawa, MK, Grebe, E, da Costa, AG, Fraiji, NA, do P. S. S. Carvalho, M, Whittaker, C, Alexander, N, Faria, NR, Dye, CM, Nascimento, VH, Busch, MP, Sabino, EC

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence by Sabino, EC, Buss, LF, Carvalho, MPS, Prete, CA, Crispim, MAE, Fraiji, NA, Pereira, RHM, Parag, KV, da Silva Peixoto, P, Kraemer, MUG, Oikawa, MK, Salomon, T, Cucunuba, ZM, Castro, MC, de Souza Santos, AA, Nascimento, VH, Pereira, HS, Ferguson, NM, Pybus, OG, Kucharski, A, Busch, MP, Dye, C, Faria, NR

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic by Buss, LF, Prete, CA, Abrahim, CMM, Mendrone, A, Salomon, T, de Almeida-Neto, C, França, RFO, Belotti, MC, Carvalho, MPSS, Costa, AG, Crispim, MAE, Ferreira, SC, Fraiji, NA, Gurzenda, S, Whittaker, C, Kamaura, LT, Takecian, PL, da Silva Peixoto, P, Oikawa, MK, Nishiya, AS, Rocha, V, Salles, NA, de Souza Santos, AA, da Silva, MA, Custer, B, Parag, KV, Barral-Netto, M, Kraemer, MUG, Pereira, RHM, Pybus, OG, Busch, MP, Castro, MC, Dye, C, Nascimento, VH, Faria, NR, Sabino, EC